Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Bimekizumab for the Treatment of Moderate to Severe Plaque Psoriasis: Efficacy, Safety, Pharmacokinetics, Pharmacodynamics and Transcriptomics from a Phase 2a Randomized, Multicenter Double-Blinded Study
Br J Dermatol 2021 Oct 23;[EPub Ahead of Print], R Oliver, JG Krueger, S Glatt, P Vajjah, C Mistry, M Page, H Edwards, S Garcet, X Li, B Dizier, A Maroof, M Watling, A El Baghdady, D Baeten, L Ionescu, S ShawFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.